Robin P. Kraak1, MD; Maik J. Grundeken1, MD; Yoshinobu Onuma2, MD, PhD; Shengxian Tu3, PhD; Joanna J. Wykrzykowska1, MD, PhD; Bernard Chevalier4, MD, PhD; John Ormiston5, MBChB; Patrick W. Serruys6*, MD, PhD
1. AMC Heartcenter, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; 2. Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands; 3. Biomedical Instrument Institute, School of Biomedical Engineering, Shanghai Jiao Tong
Bioresorbable scaffolds (BRS) provide a new tool for percutaneous treatment of coronary stenosis. Initially, relatively simple coronary artery lesions were treated with this novel technology; nowadays, we have gained more exp